Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Fuller Kevin Gregory reported acquisition or exercise transactions in this Form 4 filing.
Nature's Sunshine Products Inc. reported that Global Chief Marketing Officer Kevin Gregory Fuller received a grant of 8,984 restricted stock units (RSUs), each representing one common share at no cost. These RSUs vest in three equal annual installments from the initial grant date through May 15, 2029. Following this award, Fuller directly holds 31,548 common shares, including the granted RSUs.
Lanoy Jonathan David reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC reported that SVP and Chief Accounting Officer Jonathan David Lanoy received a grant of 6,107 common shares on May 15, 2026. The award was recorded at a price of $0.00 per share, reflecting a stock-based compensation grant rather than a market purchase.
According to the footnote, these shares are structured as restricted stock units, with each RSU representing one common share. The RSUs vest in three equal annual installments from the initial grant date through May 15, 2029. After this grant, Lanoy directly holds a total of 48,392 common shares.
Norman Daniel C reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC executive Daniel C. Norman, EVP & President, Asia, received a grant of 11,377 common shares in the form of restricted stock units. After this award, he directly holds 56,989 common shares. The RSUs vest in three equal annual installments through May 15, 2029, aligning his compensation with longer-term company performance.
Herbert Kevin R. reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC executive Kevin R. Herbert, EVP & President, North America, received an equity grant of 8,326 Common Shares in the form of restricted stock units. The grant is recorded at $0.00 per share, indicating a compensation award rather than a market purchase.
Each RSU represents one share of NATR common stock and will vest in three equal annual installments through May 15, 2029. After this award, Herbert directly holds 50,866 Common Shares, showing his total reported equity position, including this new grant.
Straus Robert D reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Robert D. Straus received an equity grant of 4,500 common-share RSUs. The award was made at no cash cost per share and will vest on the earlier of one year from the grant date or the company’s annual shareholder meeting. Following this grant, Straus directly holds 56,514 common shares.
Yang Rong reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Rong Yang received an equity award of 4,500 restricted stock units. Each RSU represents the right to receive one common share. The RSUs vest on the earlier of one year from the grant date, May 15, 2027, or the company’s next annual shareholder meeting. Following this grant, Yang is reported as holding 34,749 common shares directly.
Kopf Curtis reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Curtis Kopf received a grant of 4,500 restricted stock units (RSUs) on common shares as equity compensation. Each RSU represents one share of NATR common stock and will vest on the earlier of one year from the grant date, May 15, 2027, or the company’s annual shareholder meeting. After this award, Kopf holds 34,427 common shares directly.
Roering Tess reported acquisition or exercise transactions in this Form 4 filing.
Nature's Sunshine Products Inc. director Tess Roering received a grant of 4,500 common-share RSUs on May 15, 2026 as equity compensation, with no cash purchase price. Each restricted stock unit represents the right to receive one share of NATR common stock.
The RSUs vest on the earlier of May 15, 2027 or the occurrence of the company’s annual shareholder meeting. Following this award, Roering directly holds 34,427 common shares, including the granted RSUs.
Nature’s Sunshine Products, Inc. reported that Chief Financial Officer L. Shane Jones has resigned effective June 5, 2026, and stated that his decision was not due to any disagreement over the company’s financial reporting or accounting practices. On May 8, 2026, the company appointed longtime finance executive Jonathan D. Lanoy as Interim Principal Financial Officer. Lanoy currently serves as Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer and has been with the company’s finance organization since 2008. Under an existing employment agreement, he receives an annual base salary of $301,551, a target annual bonus equal to 50 percent of base salary, and may receive 12 months of salary and health coverage continuation if his employment ends under specified conditions.
Natures Sunshine Products EVP and General Counsel Nathan G. Brower reported compensation-related share activity tied to performance milestones. On May 5, 2026, performance-based restricted stock units vested in three tranches totaling 5,775 common shares after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. To cover tax obligations on these vestings, the company withheld a total of 1,668 common shares at a price of $25.915 per share, a tax-withholding disposition rather than an open‑market sale. After these transactions, Brower directly holds 46,452 common shares of Natures Sunshine Products.